Entourage Health Corp.

TSXV:ENTG Voorraadrapport

Marktkapitalisatie: CA$3.1m

Entourage Health Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Entourage Health's earnings have been declining at an average annual rate of -21.5%, while the Pharmaceuticals industry saw earnings growing at 46% annually. Revenues have been growing at an average rate of 14% per year.

Belangrijke informatie

-21.5%

Groei van de winst

-11.3%

Groei van de winst per aandeel

Pharmaceuticals Groei van de industrie23.1%
Inkomstengroei14.0%
Rendement op eigen vermogenn/a
Nettomarge-107.4%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Recent updates

The Market Lifts Entourage Health Corp. (CVE:ENTG) Shares 50% But It Can Do More

Oct 27
The Market Lifts Entourage Health Corp. (CVE:ENTG) Shares 50% But It Can Do More

A Piece Of The Puzzle Missing From Entourage Health Corp.'s (CVE:ENTG) 50% Share Price Climb

Sep 08
A Piece Of The Puzzle Missing From Entourage Health Corp.'s (CVE:ENTG) 50% Share Price Climb

Investors Still Aren't Entirely Convinced By Entourage Health Corp.'s (CVE:ENTG) Revenues Despite 50% Price Jump

Jul 18
Investors Still Aren't Entirely Convinced By Entourage Health Corp.'s (CVE:ENTG) Revenues Despite 50% Price Jump

Entourage Health Corp.'s (CVE:ENTG) CEO Will Probably Find It Hard To See A Huge Raise This Year

Jun 05
Entourage Health Corp.'s (CVE:ENTG) CEO Will Probably Find It Hard To See A Huge Raise This Year

Market Might Still Lack Some Conviction On Entourage Health Corp. (CVE:ENTG) Even After 50% Share Price Boost

May 31
Market Might Still Lack Some Conviction On Entourage Health Corp. (CVE:ENTG) Even After 50% Share Price Boost

Entourage Health Corp.'s (CVE:ENTG) Shares Leap 50% Yet They're Still Not Telling The Full Story

Apr 02
Entourage Health Corp.'s (CVE:ENTG) Shares Leap 50% Yet They're Still Not Telling The Full Story

Entourage Health Corp. (CVE:ENTG) Soars 50% But It's A Story Of Risk Vs Reward

Feb 08
Entourage Health Corp. (CVE:ENTG) Soars 50% But It's A Story Of Risk Vs Reward

Not Many Are Piling Into Entourage Health Corp. (CVE:ENTG) Just Yet

Apr 19
Not Many Are Piling Into Entourage Health Corp. (CVE:ENTG) Just Yet

WeedMD Inc. (CVE:WMD) On The Verge Of Breaking Even

Jan 01
WeedMD Inc. (CVE:WMD) On The Verge Of Breaking Even

Opbrengsten en kosten

Hoe Entourage Health geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

TSXV:ENTG Opbrengsten, kosten en inkomsten (CAD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 2441-44220
31 Mar 2442-43230
31 Dec 2341-46250
30 Sep 2339-117280
30 Jun 2341-124290
31 Mar 2340-124320
31 Dec 2241-123310
30 Sep 2243-80300
30 Jun 2244-80270
31 Mar 2244-81300
31 Dec 2142-79300
30 Sep 2137-80330
30 Jun 2132-89350
31 Mar 2128-88300
31 Dec 2029-90300
30 Sep 2027-51250
30 Jun 2028-39230
31 Mar 2030-17250
31 Dec 1921-10230
30 Sep 1921-11240
30 Jun 191612210
31 Mar 1910-2190
31 Dec 188-1150
30 Sep 186590
30 Jun 184-670
31 Mar 183-970
31 Dec 171-960
30 Sep 171-750
30 Jun 170-740
31 Mar 170-320
31 Dec 160-220
30 Sep 160-120
31 Dec 150-320

Kwaliteitswinsten: ENTG is currently unprofitable.

Groeiende winstmarge: ENTG is currently unprofitable.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: ENTG is unprofitable, and losses have increased over the past 5 years at a rate of 21.5% per year.

Versnelling van de groei: Unable to compare ENTG's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: ENTG is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-40.8%).


Rendement op eigen vermogen

Hoge ROE: ENTG's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden